If I'd bought $5,000 of NIB shares 5 years ago, here's how much I'd have now!

Atop the capital gains, NIB shares have also delivered two annual dividends over the past five years.

| More on:
Stethoscope with a piggy bank and hundred dollar notes.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

NIB Holdings Ltd (ASX: NHF) shares aren't joining in the broader market rally today.

The S&P/ASX 200 Index (ASX: XJO) is up 1% in early afternoon trade on Friday, while shares in the ASX 200 private health insurer are down 0.5% to $7.43 apiece.

That sees the stock down 16% since hitting fresh all-time closing highs of $8.85 on 21 June this year.

Still, you're unlikely to hear longer-term investors complaining about their returns.

If I'd bought $5,000 of NIB shares five years ago, here's how much I'd have today.

NIB shares outperform the ASX 200 over the long-run

Over the past five years the ASX 200 has gained a very respectable 36.3%.

But the health insurer's stock has outpaced those gains.

Five years ago, I could have bought NIB shares for $4.98 apiece. Meaning my $5,000 would have seen me snap up 1,004 shares, with a bit of pocket change left over.

Today those shares are swapping hands for $7.43, up 49.2%.

If I were to sell my stock today then, I'd get $7,459.72. Or a very tidy $2,459.72 in profit on my $5,000 investment. (Excluding potential brokerage fees.)

But wait. There's more.

Don't forget the dividends!

Atop the capital gains, NIB shares have also delivered two fully franked dividends for every one of the past five years. The health insurer's stock currently trades on a trailing dividend yield of 3.8%.

As for the past five years, the company has paid out a total of $1.11 in dividends.

Assuming I spent that dividend income as it came in, rather than reinvesting, then we can add that to the current share price.

This then works out to an accumulated value of $8.54 per NIB share, with some potential tax benefits from those franking credits.

That would make my 1,004 shares worth $8,574.16 today, all from my original $5,000 investment five years ago.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended NIB Holdings. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Broker says this ASX 200 biotech stock is a top buy

Let's see what Bell Potter is saying about this biotech.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why CSL shares are a buy today despite the looming Trump tariffs

A leading expert believes CSL shares are still trading for a bargain today. Here's why.

Read more »

A businesswoman pulls her glasses down in shock to look at the bad news on her computer.
Healthcare Shares

Why did the Telix share price just crash 16%?

Investors are sending the Telix share price plunging today. But why?

Read more »

Broker analysing the share price.
Healthcare Shares

Expert: 2 ASX healthcare stocks to avoid before reporting season

Not all healthcare stocks are created equal.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Should I buy Pro Medicus or CSL shares ahead of earnings season?

The ASX healthcare sector may be currently undervalued.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Healthcare Shares

Why Mesoblast shares can keep storming higher

More big returns could be on the way for buyers of this high risk stock according to Bell Potter.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »

couple having a happy discussion with a banker
Healthcare Shares

Expert: 4 ASX healthcare stocks to buy ahead of reporting season

Could these ASX healthcare stocks be good additions to your portfolio?

Read more »